Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1992 May 16;304(6837):1260–1261. doi: 10.1136/bmj.304.6837.1260

Multiple sclerosis: therapeutic pessimism.

H E Webb
PMCID: PMC1881882  PMID: 1606425

Full text

PDF
1261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. James P. B. Evidence for subacute fat embolism as the cause of multiple sclerosis. Lancet. 1982 Feb 13;1(8268):380–386. doi: 10.1016/s0140-6736(82)91402-7. [DOI] [PubMed] [Google Scholar]
  2. Trotter J. L., Hickey W. F., van der Veen R. C., Sulze L. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol. 1991 Jul;33(1):55–62. doi: 10.1016/0165-5728(91)90034-5. [DOI] [PubMed] [Google Scholar]
  3. Wajgt A., Górny M. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol Scand. 1983 Nov;68(5):337–343. doi: 10.1111/j.1600-0404.1983.tb04841.x. [DOI] [PubMed] [Google Scholar]
  4. Warren J., Sacksteder M. R., Thuning C. A. Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol. 1978 Jul;121(1):315–320. [PubMed] [Google Scholar]
  5. Yednock T. A., Cannon C., Fritz L. C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992 Mar 5;356(6364):63–66. doi: 10.1038/356063a0. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES